M Keating

4.2k total citations · 1 hit paper
52 papers, 3.3k citations indexed

About

M Keating is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, M Keating has authored 52 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Genetics, 23 papers in Hematology and 17 papers in Pathology and Forensic Medicine. Recurrent topics in M Keating's work include Chronic Lymphocytic Leukemia Research (32 papers), Acute Myeloid Leukemia Research (18 papers) and Acute Lymphoblastic Leukemia research (17 papers). M Keating is often cited by papers focused on Chronic Lymphocytic Leukemia Research (32 papers), Acute Myeloid Leukemia Research (18 papers) and Acute Lymphoblastic Leukemia research (17 papers). M Keating collaborates with scholars based in United States, United Kingdom and China. M Keating's co-authors include W. Plunkett, Elihu H. Estey, Fernando Cabanillas, Hagop M. Kantarjian, Peter McLaughlin, Varsha Gandhi, William Plunkett, Fredrick B. Hagemeister, F Swan and James M. Reuben and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Bioinformatics.

In The Last Decade

M Keating

51 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Liposomal Amphotericin B for the Treatment of Systemic Fungal Infections in Patients with Cancer: A Preliminary Study

1985 329 citations M Keating et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M Keating United States	27	1.4k	991	974	908	818	52	3.3k
EJ Freireich United States	33	1.4k 1.0×	1.8k 1.8×	996 1.0×	791 0.9×	738 0.9×	59	3.4k
Bertold Emmerich Germany	32	1.7k 1.2×	916 0.9×	1.3k 1.4×	759 0.8×	942 1.2×	114	3.5k
Philip A. Thompson United States	33	2.0k 1.4×	999 1.0×	1.6k 1.6×	838 0.9×	631 0.8×	169	3.4k
F. G. J. Hayhoe United Kingdom	30	1.0k 0.7×	1.3k 1.3×	678 0.7×	537 0.6×	957 1.2×	114	3.5k
Dina Ben‐Yehuda Israel	35	1.2k 0.8×	1.7k 1.7×	1.4k 1.4×	1.3k 1.4×	2.1k 2.5×	124	4.8k
Ulrich Jäger Austria	45	1.2k 0.8×	2.4k 2.4×	1.0k 1.1×	1.7k 1.8×	1.8k 2.2×	172	5.7k
Walter E. Aulitzky Germany	34	692 0.5×	1.1k 1.1×	420 0.4×	1.1k 1.2×	1.4k 1.7×	121	3.6k
Ellin Berman United States	31	992 0.7×	2.2k 2.2×	302 0.3×	1.2k 1.3×	1.2k 1.5×	99	3.8k
KB McCredie United States	26	1.2k 0.8×	1.7k 1.7×	421 0.4×	648 0.7×	566 0.7×	60	2.8k
Joseph G. Jurcic United States	32	547 0.4×	1.3k 1.3×	660 0.7×	1.1k 1.2×	1.2k 1.5×	135	4.2k

Countries citing papers authored by M Keating

Since Specialization

Citations

This map shows the geographic impact of M Keating's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Keating with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Keating more than expected).

Fields of papers citing papers by M Keating

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Keating. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Keating. The network helps show where M Keating may publish in the future.

Co-authorship network of co-authors of M Keating

This figure shows the co-authorship network connecting the top 25 collaborators of M Keating. A scholar is included among the top collaborators of M Keating based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Keating. M Keating is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Jinyun, Jennifer S. Carew, Marcia A. Ogasawara, et al.. (2016). Elimination of chronic lymphocytic leukemia cells in stromal microenvironment by targeting CPT with an antiangina drug perhexiline. Oncogene. 35(43). 5663–5673. 73 indexed citations

Tambaro, Francesco Paolo, Guillermo Garcia‐Manero, Susan O’Brien, et al.. (2015). Outcomes for patients with chronic lymphocytic leukemia and acute leukemia or myelodysplastic syndrome. Leukemia. 30(2). 325–330. 10 indexed citations

Coombes, Kevin R., et al.. (2004). Differences in gene expression between B-cell chronic lymphocytic leukemia and normal B cells: a meta-analysis of three microarray studies. Bioinformatics. 20(17). 3166–3178. 97 indexed citations

Lai, Raymond, George Z. Rassidakis, L. Jeffrey Medeiros, et al.. (2002). Expression of STAT3 and its phosphorylated forms in mantle cell lymphoma cell lines and tumours. The Journal of Pathology. 199(1). 84–89. 42 indexed citations

Lai, Raymond, Susan O’Brien, Anna Rogers, et al.. (2002). Prognostic value of plasma interleukin‐6 levels in patients with chronic lymphocytic leukemia. Cancer. 95(5). 1071–1075. 68 indexed citations

Hallas, Cora, et al.. (1999). Loss of FHIT expression in acute lymphoblastic leukemia.. PubMed. 5(9). 2409–14. 18 indexed citations

Kurzrock, Razelle, E Estey, S O'Brien, et al.. (1997). Second cancer risk in hairy cell leukemia: analysis of 350 patients.. Journal of Clinical Oncology. 15(5). 1803–1810. 92 indexed citations

McLaughlin, Peter, Fredrick B. Hagemeister, Jorge Romaguera, et al.. (1996). Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma.. Journal of Clinical Oncology. 14(4). 1262–1268. 219 indexed citations

McLaughlin, Peter, Fredrick B. Hagemeister, F Swan, et al.. (1994). Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma.. Journal of Clinical Oncology. 12(3). 575–579. 77 indexed citations

10.

Dimopoulos, Meletios Α., H. Kantarjian, D. Weber, et al.. (1994). Primary therapy of Waldenström's macroglobulinemia with 2-chlorodeoxyadenosine.. Journal of Clinical Oncology. 12(12). 2694–2698. 95 indexed citations

11.

Robertson, L. E., William Pugh, S O'Brien, et al.. (1993). Richter's syndrome: a report on 39 patients.. Journal of Clinical Oncology. 11(10). 1985–1989. 186 indexed citations

12.

Gandhi, Varsha, Elihu H. Estey, M Keating, & W. Plunkett. (1993). Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy.. Journal of Clinical Oncology. 11(1). 116–124. 256 indexed citations

13.

Kantarjian, H., Moshe Talpaz, Dimitrios P. Kontoyiannis, et al.. (1992). Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factor.. Journal of Clinical Oncology. 10(3). 398–405. 58 indexed citations

14.

Redman, J R, Fernando Cabanillas, W S Velasquez, et al.. (1992). Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma.. Journal of Clinical Oncology. 10(5). 790–794. 173 indexed citations

15.

Kantarjian, H., M Keating, S O'Brien, et al.. (1992). Treatment of advanced stages of Philadelphia chromosome-positive chronic myelogenous leukemia with interferon-alpha and low-dose cytarabine.. Journal of Clinical Oncology. 10(5). 772–778. 89 indexed citations

16.

Ventura, Gerard J., et al.. (1989). Analysis of risk factors for fatal hemorrhage during induction therapy of patients with acute promyelocytic leukemia.. PubMed. 3(1). 23–8. 21 indexed citations

17.

Dreizen, Samuel, et al.. (1989). Leukemia-associated skin infiltrates. Postgraduate Medicine. 85(2). 45–53. 2 indexed citations

18.

LeMaistre, A, M Keating, Ann Cork, et al.. (1989). Molecular heterogeneity in acute leukemia lineage switch. Blood. 74(6). 2088–2095. 2 indexed citations

19.

Kantarjian, Hagop M., M Keating, R S Walters, K. B. McCredie, & E. J. Freireich. (1988). The characteristics and outcome of patients with late relapse acute myelogenous leukemia.. Journal of Clinical Oncology. 6(2). 232–238. 66 indexed citations

20.

Vellekoop, L, et al.. (1981). Combination of high-dose cyclophosphamide, BCNU, and VP-16-213 followed by autologous marrow rescue in the treatment of relapsed leukemia.. PubMed. 65(5-6). 377–81. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact